Accelerating
Precision Oncology
From translational research to clinical development to commercialization, we meet your needs at every stage of drug development.
Power Your Drug Development Decision-Making With GuardantINFORM
GuardantINFORM is a robust clinical genomic real-world data solution with serial longitudinal insights powered by Guardant’s comprehensive testing portfolio.
This easily configurable dataset supports analysis for a variety of use cases and continues to rapidly expand with real-world data from our growing clinical testing volume.
Global Access to Our Proprietary Testing Solutions Is a Top Priority
Unique patients
Patients with >1 test, providing dynamic serial data
Get the Answers You Need at All Phases of Drug Development
Translational Research
Generate and validate research hypotheses to identify the right patients for therapy.
Clinical Development
Improve trial processes, predict clinical trial outcomes, and accelerate trial recruitment.
Commercialization
Optimize launch strategy and characterize unmet needs with real-world populations to inform product life-cycle planning.
Access the Largest Longitudinal Dataset for Precision Oncology
GuardantINFORM integrates information from next-generation sequencing (NGS), demographics, cancer diagnoses, treatment and procedures, and pharmacy prescription data across 60+ solid tumor cancer types.
Our data have a balanced distribution across academic and community settings, providing a comprehensive dataset with a complete picture of each patient’s journey.
Mapping the Longitudinal Patient Journey With Real-World Evidence
The GuardantINFORM™ database reconstructs a metastatic non-small cell lung cancer (mNSCLC) patient journey and assesses real-world duration of first-line advanced non-small cell lung cancer (aNSCLC) targeted therapy following circulating tumor DNA (ctDNA) biomarker identification.1
Leveraging this dataset allows you to derive standard clinical endpoints such as:
Overall survival (OS)
Time to next treatment (TTNT)
Time to treatment discontinuation (TTD)
Duration of treatment (DoT)